For the executive director of the Serum Institute of India, Adar Poonawalla, the moment of happy new year came on January 3 after the General Controller of Drugs of India on Sunday gave the final go-ahead to Covishield, the vaccine developed by the Oxford University and leading pharmaceutical Astrazeneca and …
Read More »